by editor | Oct 6, 2011 | Latest Spotlights, Medical Stocks
New U.S. Patents Provide Added Protection on Compositions of Matter for Anti-S1P Antibody Therapeutics and Methods of Treating Cancer, as Well as Cardiovascular and Cerebrovascular Disease (Dallas, TX. – October 6, 2011) StockGuru Shines its Spotlight on Lpath,...
by editor | Aug 16, 2011 | Latest Spotlights, Medical Stocks
Lpath to Conduct In Vivo Studies in Diabetic Neuropathy With LpathomabTM, Its Monoclonal Antibody Against Lysophosphatidic Acid (LPA) Dallas, Texas (August 16, 2011) – StockGuru Shines its Spotlight on Lpath, Inc. (OTCBB: LPTN), the industry leader in...
by editor | Apr 7, 2011 | Latest Spotlights
DALLAS, TEXAS : StockGuru announces that Lpath Inc. (OTCBB: LPTN) is in the StockGuru Spotlight. Lpath, a therapeutic antibody company, is the category leader in lipidomics-based therapeutics, an emerging field of medicine that targets bioactive signaling lipids...
by editor | Nov 18, 2010 | Latest Spotlights, StockGuru Blog
DALLAS, TEXAS : StockGuru announces that Lpath Inc. (OTCBB: LPTN) is in the StockGuru Spotlight. Lpath, a therapeutic antibody company, is the category leader in lipidomics-based therapeutics, an emerging field of medicine that targets bioactive signaling lipids...
by editor | Sep 10, 2010 | Latest Spotlights, StockGuru Blog
StockGuru Spotlight September 10, 2010 LPTN, PWBD, AMOK, ALME, FNSI, NEGS DPDM Dear Members: Yesterday we saw five of our StockGuru Spotlight favorites maintain or reach new highs. MXSG is up as much as 61% CECX is up as much as 49% MASC is up as much as 40% XTGR is...